Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pyle

Showing results (11-20 of 260) with videos related to

Pageof 26
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|December 31, 2015
Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determinedLaura Pyle, Bryan C Bergman, Kristen J Nadeau, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Comparison of Cgmanalysis, a Free Open-Source Continuous Glucose Monitoring Data Management and Analysis Software, with Commercially Available CGM Platforms: Data Standardization for Diabetes Technology ResearchHalis Kaan Akturk, Tim Vigers, Gregory Forlenza, et al.
Journal of Health Care for the Poor and Underserved|January 8, 2021
Favorable Sustained Virologic Response Rates Using Direct-Acting Antiviral Therapies at a Large Safety-Net HospitalAndrew Bryant, Avash Kalra, Aimee Truesdale, et al.
Journal of Diabetes Science and Technology|September 25, 2023
Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor UseHalis K Akturk, Casey Sakamoto, Tim Vigers, et al.
Diabetes Technology & Therapeutics|February 15, 2023
Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without DiabetesViral N Shah, Tim Vigers, Laura Pyle, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Network approach reveals preferential T-cell and macrophage association with α-linked β-cells in early stage of insulitis in NOD miceNirmala V Balasenthilkumaran, Jennifer C Whitesell, Laura Pyle, et al.
Diabetes Technology & Therapeutics|February 28, 2020
Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell TransplantationJenna Sopfe, Tim Vigers, Laura Pyle, et al.
Diabetes Technology & Therapeutics|February 12, 2025
Correlation Between A1c and Continuous Glucose Monitor Time in Range in a Cohort of Pediatric Patients with Type 1 DiabetesMarisa Sobczak, Laura Pyle, Alexandra Sawyer, et al.
Journal of Diabetes|August 13, 2024
Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?Rebecca Ohman-Hanson, G Todd Alonso, Laura Pyle, et al.
The Journal of Clinical Endocrinology and Metabolism|September 19, 2021
The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic FibrosisChristine L Chan, Laura Pyle, Tim Vigers, et al.
Pageof 26

Showing results (11-20 of 260) with videos related to

Sort By:
Pageof 26
American Journal of Physiology. Endocrinology and Metabolism|December 31, 2015
Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determinedLaura Pyle, Bryan C Bergman, Kristen J Nadeau, et al.
Diabetes Technology & Therapeutics|September 15, 2021
Comparison of Cgmanalysis, a Free Open-Source Continuous Glucose Monitoring Data Management and Analysis Software, with Commercially Available CGM Platforms: Data Standardization for Diabetes Technology ResearchHalis Kaan Akturk, Tim Vigers, Gregory Forlenza, et al.
Journal of Health Care for the Poor and Underserved|January 8, 2021
Favorable Sustained Virologic Response Rates Using Direct-Acting Antiviral Therapies at a Large Safety-Net HospitalAndrew Bryant, Avash Kalra, Aimee Truesdale, et al.
Journal of Diabetes Science and Technology|September 25, 2023
Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor UseHalis K Akturk, Casey Sakamoto, Tim Vigers, et al.
Diabetes Technology & Therapeutics|February 15, 2023
Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without DiabetesViral N Shah, Tim Vigers, Laura Pyle, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Network approach reveals preferential T-cell and macrophage association with α-linked β-cells in early stage of insulitis in NOD miceNirmala V Balasenthilkumaran, Jennifer C Whitesell, Laura Pyle, et al.
Diabetes Technology & Therapeutics|February 28, 2020
Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell TransplantationJenna Sopfe, Tim Vigers, Laura Pyle, et al.
Diabetes Technology & Therapeutics|February 12, 2025
Correlation Between A1c and Continuous Glucose Monitor Time in Range in a Cohort of Pediatric Patients with Type 1 DiabetesMarisa Sobczak, Laura Pyle, Alexandra Sawyer, et al.
Journal of Diabetes|August 13, 2024
Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?Rebecca Ohman-Hanson, G Todd Alonso, Laura Pyle, et al.
The Journal of Clinical Endocrinology and Metabolism|September 19, 2021
The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic FibrosisChristine L Chan, Laura Pyle, Tim Vigers, et al.
Pageof 26